BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

SK Telecom ties up with biotech firm to develop AI genome analysis solutions

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : August 20, 2018, 10:52 | Updated : August 20, 2018, 10:52
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of SK Telecom]


SEOUL -- South Korea's top mobile carrier SK Telecom has forged a strategic partnership with Macrogen, a domestic biotechnology company known for personalized genomic medicine, to commercialize personalized treatment by developing genome analysis solutions using artificial intelligence (AI) technology

Genomic analysis is identifying DNA mutations, sequence information, and disease information. It can help predict the incidence of cancer and rare diseases and find a suitable treatment. Genetic analysis would be able to find and administer the most appropriate anticancer drug for an individual patient.

SK Telecom said in a statement Monday that it would build an AI system that would analyze, accumulate and manage a large amount of genome data and medical information possessed by Macrogen. SK Telecom plans to provide its compressed storage technology so that hospitals and research institutes can store data without additional storage to secure data storage space.

SK Telecom has developed technologies related to AI and the Internet of Things (IoT). Macrogen's business model focuses on providing research services to other firms engaged in biotechnology research and development.

Both companies will use AI technology to develop solutions that can quickly analyze integrated data such as disease, family history and lifestyle and individual genome information from hospitals and institutions. SK Telecom said that with the help of AI genome analysis solutions, hospitals will be able to tailor individualized treatment. Pharmaceutical companies can use data to develop intractable disease drugs.

"The artificial intelligence will play an important role in leading the change and innovation of the medical field," SK Telecom's IoT and data division chief Chang Hong-sung was quoted as saying. "We will work with Macrogen to reduce the time and cost of genome analysis and make more people use it for treatment.

"We hope Macrogen's genomic data will be easily accessible to more people through SK Telecom's ICT technology," Microgen CEO Yang Kap-seok said. "We will make more efforts to ensure that patients receive high-quality medical services based on precision medicine."

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .S. Korean and Australian biotech firms join hands to develop exosome-based therapies.
    S. Korean and Australian biotech firms join hands to develop…
  • .Daewoong claims to have scored initial victory in botox patent war with domestic rival.
    Daewoong claims to have scored initial victory in botox pate…
  • .[Coronavirus] Researchers open new direction to investigate virus mechanism.
    [Coronavirus] Researchers open new direction to investigate …
  • .Biotech companies selected for state project to establish big data in biology.
    Biotech companies selected for state project to establish bi…

Real Time Photo News

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

  • .​Solo singer Sunmi to come back with new album Tail.

    ​Solo singer Sunmi to come back with new album 'Tail'

  • .Big Hits live-streaming joint venture gains reinforcements from Universal Music, YG.

    Big Hit's live-streaming joint venture gains reinforcements from Universal Music, YG

Latest News

more+

  • Prime Minister Chung stresses importance of 'borderless communication channel' to minimize informati…
  • State hospital succeeds in inserting wireless pacemakers into hearts of bradyarrhythmia patients
  • LG Electronics' joint venture with Canada's Magna awaits approval by shareholders in March
  • Sajo Seafood to launch raw tuna menu delivery service
  • Researchers find new roundworm species near Dokdo
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view